Posted by Gigi J.K
in Ai
in Ai
GTM vs Growth Strategy: Why B2B Founders Keep Buying the Wrong Thing
Why “GTM Strategy” Is the Most Expensive Mislabel in B2B
A founder raises a Series A. The board wants a pipeline. The CEO hires a fractional CMO and signs a 12-month contract with a GTM consultancy for thirty grand a month. The deliverables arrive on time. A sharpened ICP. A new messaging framework. An outbound sequence running across three channels. A tighter sales deck. Six months in, the dashboard looks great. Meetings booked are up 40 percent. Sales-qualified leads are up. Pipeline is fat.
Revenue is flat.
The consultant blames the sales team. The sales team blames the leads. The CMO blames the product. The founder blames the consultant. Nobody is entirely right, and nobody is entirely wrong. But they all missed the same thing.
They bought GTM when they needed a growth strategy. And nobody told them those are not the same thing.
Table of Contents
The mislabel that costs B2B companies millions
Ask ten founders, ten VCs, and ten operators to explain the difference between go-to-market strategy and growth strategy. You will get thirty different answers, most of them wrong, and a few that sound right but collapse the moment you press on them.
Here is the cleanest version. Growth strategy is where revenue comes from over the next one to five years and what makes it defensible. Go-to-market strategy is how you put a specific offer in front of specific buyers efficiently.
Growth strategy asks questions like: Which markets should we enter and in what order? Which customer segments deserve our best resources? What moat are we building while we grow? How do we price the compound margin over time? When do we expand the product line, and when do we stay disciplined?
Go-to-market strategy asks questions like: Who is the ideal buyer for this offer? What is the sharpest way to position it? Which channels reach those buyers? What sales motion fits the price point? How do we hand off from marketing to sales to customer success?
One is the map. The other is the route. You can have a brilliant route on a map pointing the wrong direction, and that is exactly what most B2B companies end up with when they buy GTM help without a growth strategy underneath it.
Why the two got tangled in the first place
At pre-seed and seed, growth strategy and GTM basically are the same thing. One product. One segment. One channel that seems to work. The question “how do we sell this?” is the whole game.
The industry froze that early-stage reality into vocabulary and never updated it. A company hits ten million in revenue, starts adding products, opens new segments, watches retention soften, and still talks about “GTM” as if that single term describes everything commercial. It does not. The problems have multiplied. The vocabulary has not.
Add to this a supply side of fractional CMOs, agencies, and consultants who sell GTM engagements because that is what they are set up to deliver. Ask a firm that sells outbound systems whether you need outbound, and the answer is always yes. Ask them whether your problem might be upstream or outbound, and most cannot give you a useful answer because the business model does not reward that honesty.
Even Gartner’s own framework acknowledges this, noting that the crucial alignment between an organization’s growth strategy and its GTM strategy framework is what most sales leaders struggle to get right. The two are related. They are not the same.
The result is predictable. B2B companies keep buying the same GTM projects, getting the same uneven results, and wondering why the playbook that worked at two million dollars has stopped working at twelve million.
Four symptoms of a growth strategy problem dressed up as a GTM problem
Here are four patterns that show up again and again. If any of them sound familiar, the work you need is not what you think it is.
Symptom one. The pipeline is full but revenue is flat.
You are generating meetings. You are booking demos. Win rates are not moving. Average contract value is not moving. Or worse, the sales cycle keeps stretching and discounts keep growing. This is almost never a top-of-funnel problem. More leads into a leaky funnel produces more leaks, not more revenue. The actual issue is usually pricing and packaging, ICP precision, or a positioning gap that makes every deal feel like a custom negotiation. A GTM consultant will tell you to tighten the messaging. That helps at the margin. What actually moves the number is redesigning the offer itself, and that is growth strategy work.
Symptom two. You win logos and lose them in year two.
New-business acquisition is healthy. Net revenue retention is under 100 percent. Churn is quiet, polite, and relentless. Every new customer you add is replacing one you just lost, and the treadmill gets more expensive every quarter because customer acquisition costs keep rising while the lifetime value stays short. No acquisition motion outruns a leaky bucket. The real work is understanding why your best customers stay and your worst ones leave, then redesigning onboarding, success, product, or segmentation around that insight. None of that lives inside a GTM engagement.
Symptom three. Objectively weaker competitors keep beating you.
You look at the competitor that just won a deal you should have won, and their product is worse, their team is thinner, their references are shakier. You lose anyway. This happens when a competitor has sharper positioning and a clearer point of view while you have better features and a fuzzier story. Features lose clarity every time. GTM tactics cannot fix this because the problem is strategic, not tactical. You need a point of view the market can feel, and that requires rethinking what you stand for, not what you say in the next email sequence.
Symptom four. Every channel works for a quarter and then dies.
Paid ads popped for two quarters and then CAC tripled. Outbound worked until it did not. The webinar motion drove the pipeline, then stopped. You keep rotating through channels like a gambler trying to find a hot slot machine. This is a segmentation problem disguised as a channel problem. If your ICP is too broad or too shallow, every channel will eventually burn out because you are not building compounding equity with any one audience. GTM consultants will keep suggesting new channels to test. The real fix is narrowing who you sell to until the channel economics make sense.
In each case, the cost of the wrong diagnosis is similar. Twelve to eighteen months of time. Six to seven figures in consulting fees and team cost. And the opportunity cost of a board and a management team believing they have done the work when they have not even started it.
How to tell the difference before you spend a dollar
Before scoping any growth or GTM engagement, walk through three questions honestly.
First. Is the problem acquiring customers, or is it what happens after we acquire them? If the answer is the second one, no amount of GTM work will fix it. You need to look upstream of acquisition.
Second. If we doubled the pipeline tomorrow, would revenue double? Or would the same structural issue just get louder? If the issue gets louder, you have a growth strategy problem. Pouring fuel on a fire that is burning the wrong house down does not help.
Third. Do we know why our best customers stay and our worst ones churn? If you are guessing, the foundation is not there yet. You cannot build an efficient GTM motion on top of a segmentation and retention model you do not actually understand.
If the honest answers point to anything downstream of acquisition, you have a growth strategy problem. GTM becomes the right project only after the growth questions are settled.
What to do instead
The sequence matters more than the labels.
If you are pre-product-market-fit, you need GTM experimentation, not growth strategy. Do not over-engineer. Run small bets, talk to buyers, iterate fast. The growth strategy question is premature because there is not yet a repeatable engine to strategize around.
If you are post-product-market-fit but stalling, run a growth diagnostic before scoping any GTM engagement. The diagnosis determines whether GTM is even the right project, or whether the real work is pricing, positioning, retention, or segmentation. Different symptoms point to different root causes, and the right lens depends on the problem. At ImpelHub, we use a [family of diagnostic frameworks]([INTERNAL LINK TO METHODOLOGY PAGE]) to match the problem to the right intervention, because no single framework diagnoses everything.
If you are scaling, growth strategy leads and GTM is one of several playbooks executing against it. At this stage, GTM without strategic direction from above becomes expensive motion, not momentum. The board will feel it before the dashboard does.
The Bottom Line
The reason “GTM strategy” has become the most expensive mislabel in B2B is not that GTM work is unimportant. It is essential. The problem is that GTM has become the default answer to a question founders have not actually asked clearly. “We need more revenue” gets translated into “we need GTM help” because GTM is the thing you buy. Growth strategy is harder to scope, harder to sell, and harder to deliver, which means fewer firms sell it and fewer founders know to ask for it.
The founders who outperform are the ones who diagnose before they prescribe. They find out what kind of problem they actually have before they hire anyone to fix it. Sometimes the answer is GTM. Often it is not. Either way, the diagnosis costs less than the wrong engagement, and it saves the year.
Frequently Asked Questions (FAQs)
Is GTM the same as a growth strategy?
No. GTM is a subset of growth strategy. Growth strategy defines where revenue comes from over one to five years and what makes it defensible. GTM defines how a specific offer reaches specific buyers efficiently. A company can have a strong GTM motion executing against a weak growth strategy, which is the most common reason B2B companies stall between five and twenty million in revenue.
What is the difference between GTM and growth strategy?
Growth strategy is the broader plan covering markets, segments, pricing architecture, retention, competitive moats, and product roadmap. GTM is specifically the acquisition and launch motion for an offer. Growth strategy answers “where should growth come from and why is it defensible.” GTM answers “how do we get this offer to buyers efficiently.”
When do I need GTM help vs growth strategy help?
You need GTM help when the problem is acquiring customers. You need growth strategy help when the problem is what happens after you acquire them: retention, pricing, positioning, segmentation, or product-market fit. If doubling your pipeline tomorrow would not double your revenue, GTM is the wrong project.
Can GTM fix a growth strategy problem?
No. GTM improves acquisition efficiency. It cannot fix a broken pricing model, a leaky retention curve, fuzzy positioning, or segment-channel mismatch. Running GTM on top of a growth strategy problem usually makes the problem more expensive, not less.
How much does the wrong diagnosis cost?
Typically twelve to eighteen months of time and six to seven figures in combined consulting fees, team cost, and opportunity cost. The most expensive cost is usually the board and management team believing the work has been done when it has not.
What is a growth diagnostic?
A growth diagnostic is a structured assessment that identifies the root cause of revenue stall before prescribing an intervention. It examines funnel shape, retention curves, pricing elasticity, positioning clarity, and segment economics to determine whether the company needs GTM work, pricing work, positioning work, retention work, or a combination. Diagnosis precedes prescription.
